JNJonah Ng

Jonah Ng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jonah Ng has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Jaydeep Roy

    Center of Excellence for Brain Health and Neurotechnology, Academy of Life and Natural Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, China; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong, China

    1 shared publication
  • Ka Chun Tsui

    Center of Excellence for Brain Health and Neurotechnology, Academy of Life and Natural Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, China; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong, China

    1 shared publication
  • Lee Wei Lim

    DrLim Neuromodulation Lab, Department of Biosciences and Bioinformatics, School of Science, Xi’an Jiaotong-Liverpool University, Suzhou 215123, China

    1 shared publication
  • Man-Lung Fung

    School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    1 shared publication

Latest Publications

  • Open Access

    Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease

    by Jaydeep Roy, Ka Chun Tsui, Jonah Ng, Man-Lung Fung, Lee Wei Lim

    Alzheimer’s disease is a neurodegenerative disorder associated with age, and is characterized by pathological markers such as amyloid-beta plaques and neurofibrillary tangles. Symptoms of AD include cognitive impairments, anxiety and depression. It has also been shown that individuals with AD have impaired neurotransmission, which may result from the accumulation of amyloid plaques and neurofibrillary tangles. Preclinical studies showed that melatonin, a monoaminergic neurotransmitter released from the pineal gland, is able to ameliorate AD pathologies and restore cognitive impairments. Theoretically, inhibition of the pathological progression of AD by melatonin treatment should also restore the impaired neurotransmission. This review aims to explore the impact of AD on neurotransmission, and whether and how melatonin can enhance neurotransmission via improving AD pathology.